Wassen F W, Moerings E P, Van Toor H, De Vrey E A, Hennemann G, Everts M E
Department of Internal Medicine III, Erasmus University Medical School, Rotterdam, The Netherlands.
Endocrinology. 1996 May;137(5):1591-8. doi: 10.1210/endo.137.5.8612490.
The effects of interleukin-1 beta (IL-1 beta) and tumor necrosis factor-alpha (TNF alpha) on basal and TRH-induced TSH release, and the effects of IL-1 beta on the uptake of [125I]T3 and [125I]T4 and on nuclear binding of [125I]T3 were examined. Furthermore, the release of other anterior pituitary hormones in the presence of IL-1 beta was measured. Anterior pituitary cells from male Wistar rats were cultured for 3 days in medium containing 10% FCS. Incubation were performed at 37 C in medium with 0.5% BSA for measurement of [125I]T3 uptake and with 0.1% BSA for measurement of [125I]T4 uptake. Exposure to IL-1 beta (1 pM-1 nM) or TNF alpha (100 pM) for 2-4 h resulted in a significant decline in TSH release, which was almost 50% (P < 0.05) for 1 nM IL-1 beta and 24% (P < 0.05) for 100 pM TNF alpha. Measurement of other anterior pituitary hormones (FSH, LH, PRL, and ACTH) in the same incubation medium showed that IL-1 beta did not alter their release. When the effects of IL-1 beta (1 pM-1 nM) and TNF alpha (100 pM) on TRH-induced TSH release were measured in short term experiments, the inhibitory effects had disappeared. The addition of 1-100 nM octreotide, a somatostatin analog, resulted in a decrease in TRH-induced TSH release up to 33% of the control value (P < 0.05). Exposure to dexamethasone (1 nM to 1 microM) affected basal and TRH-induced TSH release similar to the effect of IL-1 beta. The 15-min uptake of [125I]T3 and [125I]T4, expressed as femtomoles per pM free hormone, was not affected by the presence of IL-1 beta (1-100 pM). When IL-1 beta (100 pM) was present during 3 days of culture, TSH release was reduced to 88 +/- 2% of the control value (P < 0.05). This effect was not associated with an altered [125I]T3 uptake (15 min to 4 h) or with any change in nuclear T3 binding. We conclude that 1) IL-1 beta decreases TSH release by a direct action on the pituitary; 2) this effect is not due to elevated thyroid hormone uptake or increase T3 nuclear occupancy; 3) IL-1 beta does not affect TRH-induced TSH release or the release of other anterior pituitary hormones; and 4) TNF alpha affects basal and TRH-induced TSH release in the same way as IL-1 beta.
研究了白细胞介素 -1β(IL -1β)和肿瘤坏死因子 -α(TNFα)对基础状态及促甲状腺激素释放激素(TRH)诱导的促甲状腺激素(TSH)释放的影响,以及IL -1β对[125I]T3和[125I]T4摄取及[125I]T3核结合的影响。此外,还测定了存在IL -1β时其他垂体前叶激素的释放情况。将雄性Wistar大鼠的垂体前叶细胞在含10%胎牛血清(FCS)的培养基中培养3天。在37℃下,于含0.5%牛血清白蛋白(BSA)的培养基中进行孵育以测量[125I]T3摄取,在含0.1% BSA的培养基中进行孵育以测量[125I]T4摄取。暴露于IL -1β(1 pM - 1 nM)或TNFα(100 pM)2 - 4小时导致TSH释放显著下降,对于1 nM IL -1β下降近50%(P < 0.05),对于100 pM TNFα下降24%(P < 0.05)。在相同孵育培养基中对其他垂体前叶激素(促卵泡激素(FSH)、促黄体生成素(LH)、催乳素(PRL)和促肾上腺皮质激素(ACTH))的测量表明,IL -1β未改变它们的释放。在短期实验中测量IL -1β(1 pM - 1 nM)和TNFα(100 pM)对TRH诱导的TSH释放的影响时,抑制作用消失。添加1 - 100 nM奥曲肽(一种生长抑素类似物)导致TRH诱导的TSH释放下降至对照值的33%(P < 0.05)。暴露于地塞米松(1 nM至1 μM)对基础状态及TRH诱导的TSH释放的影响与IL -1β类似。以每皮摩尔游离激素的飞摩尔数表示的[125I]T3和[125I]T4的15分钟摄取不受IL -1β(1 - 100 pM)存在的影响。当在培养3天期间存在IL -1β(100 pM)时,TSH释放降至对照值的88±2%(P < 0.05)。这种效应与[125I]T3摄取改变(15分钟至4小时)或核T3结合的任何变化无关。我们得出结论:1)IL -1β通过对垂体的直接作用降低TSH释放;2)这种效应不是由于甲状腺激素摄取增加或T3核占有率增加;3)IL -1β不影响TRH诱导的TSH释放或其他垂体前叶激素的释放;4)TNFα对基础状态及TRH诱导的TSH释放的影响与IL -1β相同。